Mariaelena Pierobon Selected Research

Mariaelena Pierobon Research Topics

Disease

41	Neoplasms (Cancer) 03/2024 - 09/2007
9	Breast Neoplasms (Breast Cancer) 01/2024 - 04/2008
8	Neoplasm Metastasis (Metastasis) 11/2020 - 04/2008
6	Colorectal Neoplasms (Colorectal Cancer) 07/2017 - 03/2009
4	Lung Neoplasms (Lung Cancer) 10/2021 - 10/2015
4	Carcinogenesis 01/2020 - 01/2011
3	Carcinoma (Carcinomatosis) 01/2024 - 07/2021
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 10/2015
2	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 08/2017
2	Adenocarcinoma 01/2022 - 11/2021
2	Fibrosis (Cirrhosis) 01/2019 - 12/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 12/2016
2	Melanoma (Melanoma, Malignant) 12/2015 - 10/2008
1	Uterine Neoplasms (Uterine Cancer) 01/2024
1	Medulloblastoma 01/2022
1	Multiple Myeloma 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Inflammation (Inflammations) 01/2019
1	Pancreatic Ductal Carcinoma 01/2019
1	Non-alcoholic Fatty Liver Disease 12/2018
1	Adenocarcinoma of Lung 10/2017
1	Ovarian Epithelial Carcinoma 01/2015
1	Disease Progression 10/2014
1	Triple Negative Breast Neoplasms 01/2013
1	Rectal Neoplasms (Rectal Cancer) 12/2012
1	Chronic Hepatitis C 02/2011
1	Leiomyoma (Uterine Fibroids) 10/2008

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 03/2024 - 09/2007
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2009
5	Phosphotransferases (Kinase)IBA 11/2023 - 10/2015
5	PhosphoproteinsIBA 01/2020 - 04/2008
3	RNA (Ribonucleic Acid)IBA 01/2024 - 06/2021
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 12/2015
2	Hormones (Hormone)IBA 01/2024 - 11/2019
2	LigandsIBA 10/2021 - 11/2019
2	Protein Kinases (Protein Kinase)IBA 01/2019 - 07/2017
2	ProteomeIBA 12/2018 - 03/2011
1	trastuzumab deruxtecanIBA 01/2024
1	Trastuzumab (Herceptin)FDA Link 01/2024
1	pertuzumabIBA 01/2024
1	Monoclonal AntibodiesIBA 01/2024
1	GTP Phosphohydrolases (GTPases)IBA 12/2023
1	GuanosineIBA 12/2023
1	Karyopherins (Importin)IBA 01/2022
1	Farnesyltranstransferase (Farnesyltransferase)IBA 01/2022
1	tipifarnib (R115777)IBA 01/2022
1	Chloroquine (Aralen)FDA LinkGeneric 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2022
1	selinexorIBA 01/2022
1	atezolizumabIBA 10/2021
1	NivolumabIBA 10/2021
1	Programmed Cell Death 1 ReceptorIBA 10/2021
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 03/2021
1	PlatinumIBA 01/2021
1	adagrasibIBA 01/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020
1	Estrogen ReceptorsIBA 11/2019
1	Androgen Receptors (Androgen Receptor)IBA 11/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	GastrinsIBA 01/2019
1	130-nm albumin-bound paclitaxelIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	CollagenIBA 12/2018
1	MTOR InhibitorsIBA 01/2018
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 08/2017
1	Carboplatin (JM8)FDA LinkGeneric 08/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2017
1	MK 2206IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 12/2016
1	Interleukin-8 (Interleukin 8)IBA 12/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 12/2015
1	dabrafenibIBA 12/2015
1	trametinibIBA 12/2015
1	Estrogen Receptor alphaIBA 10/2015
1	tyrosine receptor (receptor, tyrosine)IBA 10/2015
1	Estrogens (Estrogen)FDA Link 10/2015
1	Matrix Metalloproteinases (MMPs)IBA 10/2014
1	ErbB Receptors (EGF Receptor)IBA 12/2012
1	InterferonsIBA 02/2011
1	Ribavirin (Virazole)FDA LinkGeneric 02/2011
1	AMP-Activated Protein KinasesIBA 10/2008
1	Caspase 3 (Caspase-3)IBA 10/2008
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 10/2008

Therapy/Procedure

19	Therapeutics 01/2024 - 09/2007
17	Lasers (Laser) 03/2024 - 04/2008
5	Drug Therapy (Chemotherapy) 01/2024 - 03/2011
5	Precision Medicine 10/2021 - 10/2015
1	Radiotherapy 01/2018
1	Neoadjuvant Therapy 12/2012
1	Chemoradiotherapy 12/2012